Showing results (21-30 of 63) with videos related to
Sort By:
Pageof 7
Plos One|June 10, 2011
A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1Dimitrios Coutsinos, Cédric F Invernizzi, Daniela Moisi, et al.The Journal of Antimicrobial Chemotherapy|October 5, 2014
Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistanceIsabelle Hardy, Bluma Brenner, Peter Quashie, et al.Antimicrobial Agents and Chemotherapy|December 10, 2008
Nucleoside and nucleotide analogs select in culture for different patterns of drug resistance in human immunodeficiency virus types 1 and 2Michel L Ntemgwa, Thomas d'Aquin Toni, Bluma G Brenner, et al.Antimicrobial Agents and Chemotherapy|December 8, 2010
Characterization of the E138K resistance mutation in HIV-1 reverse transcriptase conferring susceptibility to etravirine in B and non-B HIV-1 subtypesEugene L Asahchop, Maureen Oliveira, Mark A Wainberg, et al.Antimicrobial Agents and Chemotherapy|January 28, 2009
Detection of human immunodeficiency virus (HIV) type 1 M184V and K103N minority variants in patients with primary HIV infectionThomas A Toni, Eugene L Asahchop, Daniela Moisi, et al.AIDS (London, England)|December 25, 2012
Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baselineEugene L Asahchop, Mark A Wainberg, Maureen Oliveira, et al.Antimicrobial Agents and Chemotherapy|June 19, 2002
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RTHugues Loemba, Bluma Brenner, Michael A Parniak, et al.Antimicrobial Agents and Chemotherapy|July 27, 2004
Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1Dan Turner, Bluma Brenner, Daniela Moisi, et al.Journal of Medical Virology|March 2, 2011
Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitorsBluma G Brenner, Matthew Lowe, Daniela Moisi, et al.Antiviral Research|October 9, 2002
Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistanceHugues Loemba, Bluma Brenner, Michael A Parniak, et al.Pageof 7